VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $91,799,000 | -18.1% | 413,232 | -26.8% | 9.50% | -9.2% |
| Q1 2015 | $112,068,000 | +32.0% | 564,232 | -4.9% | 10.47% | +37.8% |
| Q4 2014 | $84,897,000 | -0.2% | 593,232 | -8.5% | 7.60% | -8.4% |
| Q3 2014 | $85,091,000 | -42.1% | 648,561 | -44.3% | 8.29% | -24.5% |
| Q2 2014 | $146,955,000 | +30.7% | 1,165,200 | +36.6% | 10.98% | +4.6% |
| Q1 2014 | $112,477,000 | +3.3% | 853,200 | -8.0% | 10.50% | +11.4% |
| Q4 2013 | $108,853,000 | -5.1% | 927,200 | -15.7% | 9.42% | -21.3% |
| Q3 2013 | $114,711,000 | +17.7% | 1,099,500 | -2.9% | 11.97% | +17.0% |
| Q2 2013 | $97,486,000 | – | 1,132,500 | – | 10.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |